secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibikase Therapeutics, Inc. (IKT)
CIK:        0001750149
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001193125-23-076674
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inhibikase Therapeutics holds R&D Day; presentation content not fully available in filing
--------------------------------------------------------------------------------

- Company presented to investors at R&D Day on March 22, 2023.
- The 8-K includes presentation as Exhibit 99.1 but only title slide and disclaimer are visible in the filing excerpt.
- No specific pipeline data, financial figures, or clinical milestones are extractable from the provided text.
- Investors should consult the full presentation on the company's website or other SEC filings for details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750149/000119312523076674/0001193125-23-076674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750149/000119312523076674/d485707d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-076674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer